90
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis

, , , , , , , , , , , & show all
Pages 519-524 | Published online: 17 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Eric H. Souied, Pravin U. Dugel, Alberto Ferreira, Ron Hashmonay, Jingsong Lu & Simon P. Kelly. (2016) Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis. Ophthalmic Epidemiology 23:2, pages 71-79.
Read now
Milena L Cavalcante, Victor M Villegas, Aaron S Gold, Ludimila L Cavalcante, Marcela Lonngi, Nisha V Shah & Timothy G Murray. (2014) Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab. Clinical Ophthalmology 8, pages 1377-1382.
Read now
Nisha V Shah, Samuel K Houston, Arnold Markoe & Timothy G Murray. (2013) Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma. Clinical Ophthalmology 7, pages 1877-1882.
Read now

Articles from other publishers (19)

Sean Platt, Diva R. Salomao & Jose Pulido. (2021) Histologic Findings of Choroidal Vasculopathy in Eyes Enucleated following Radiation Therapy for Uveal Melanoma: Radiation Choroidopathy. Klinische Monatsblätter für Augenheilkunde 238:05, pages 584-590.
Crossref
. (2021) Bevacizumab. Reactions Weekly 1850:1, pages 78-78.
Crossref
Yanyun Chen, Wenbin Wei, Demetrios G. Vavvas, Feng Zhang, Haicheng She, Haiying Zhou, Lei Li, Yao Huang, Dimitrios P. Ntentakis & Xiangyu Shi. (2020) Incidence of Endophthalmitis after Intravitreal Anti-Vascular Endothelial Growth Factor Injections in an Operating Room in China. Journal of Ophthalmology 2020, pages 1-6.
Crossref
A. Chronopoulos, P. Schwarz, L. Fornoff & L.-O. Hattenbach. (2018) Vitrektomie bei EndophthalmitisVitrectomy for endophthalmitis. Der Ophthalmologe 116:8, pages 746-752.
Crossref
Joachim Van Calster, Koen Willekens, Deborah Seys, Peter Van Elderen, Werner Spileers & Kris Vanhaecht. (2018) Standardized care by redesign of an intravitreal injection pathway. European Journal of Ophthalmology 29:1, pages 92-99.
Crossref
Michele ReibaldiAlfredo PulvirentiTeresio AvitabileVincenza BonfiglioAndrea RussoCesare MariottiClaudio Bucolo, Rodolfo MastropasquaGuglielmo ParisiAntonio Longo. (2018) POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS. Retina 38:1, pages 01-11.
Crossref
Morteza Entezari, Saeed Karimi, Hamid Ahmadieh, Amir Hossein Mahmoudi, Hamid Parhizgar & Mehdi Yaseri. (2016) A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab. Graefe's Archive for Clinical and Experimental Ophthalmology 254:9, pages 1851-1856.
Crossref
Jae Hyung HwangJeong Hyun LeeJae Suk Kim. (2016) Phacoemulsification and Intraocular Lens Implantation after Unexpected Intralenticular Injection of a Dexamethasone Implant. Journal of the Korean Ophthalmological Society 57:4, pages 662.
Crossref
Darlene Miller. 2016. Endophthalmitis. Endophthalmitis 49 75 .
Taraprasad Das, Srinivas Volety, Saad M Ahsan, Abhay K Thakur, Savitri Sharma, Tapas R Padhi, Soumyava Basu & Ch Mohan Rao. (2015) Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab. Clinical & Experimental Ophthalmology 43:5, pages 466-473.
Crossref
Javier Coca-Robinot, Bruno Casco-Silva, Felix Armadá-Maresca & Jesús García-Martínez. (2018) Accidental Injections of Dexamethasone Intravitreal Implant (Ozurdex ® ) into the Crystalline Lens . European Journal of Ophthalmology 24:4, pages 633-636.
Crossref
Alexander M. Eaton, Gabriel M. Gordon, Hussein Wafapoor, Adam Sgarlata & Robert L. Avery. (2013) Assessment of Novel Guarded Needle to Increase Patient Comfort and Decrease Injection Time During Intravitreal Injection. Ophthalmic Surgery, Lasers and Imaging Retina 44:6, pages 561-568.
Crossref
S. Koller, T. Neuhann & I. Neuhann. (2012) Auffälliger Linsenfremdkörper nach intravitrealer InjektionConspicuous crystalline lens foreign body after intravitreal injection. Der Ophthalmologe 109:11, pages 1119-1121.
Crossref
Leopold Schmetterer & Gerhard Garhöfer. (2012) Pharmakologische Basis der Anti-VEGF TherapiePharmacological basis of the anti-VEGF therapy. Spektrum der Augenheilkunde 26:4, pages 185-196.
Crossref
Janice R. Safneck. (2012) Endophthalmitis: A review of recent trends. Saudi Journal of Ophthalmology 26:2, pages 181-189.
Crossref
Cristina Irigoyen, Kimia Ziahosseini, George Morphis, Theodor Stappler & Heinrich Heimann. (2011) Endophthalmitis following intravitreal injections. Graefe's Archive for Clinical and Experimental Ophthalmology 250:4, pages 499-505.
Crossref
Phoebe Lin & Eugene de JuanJrJr. 2012. Ophthalmic Surgery: Principles and Practice. Ophthalmic Surgery: Principles and Practice 510 518 .
Shabari S Bhatt, Kimberly E Stepien & Komal Joshi. (2011) PROPHYLACTIC ANTIBIOTIC USE AFTER INTRAVITREAL INJECTION. Retina 31:10, pages 2032-2036.
Crossref
Eric Chen, Michael Y Lin, Joel Cox & David M Brown. (2011) ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION. Retina 31:8, pages 1525-1533.
Crossref